Raymond James & Associates Boosts Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Raymond James & Associates grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 200.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 50,047 shares of the company's stock after acquiring an additional 33,414 shares during the period. Raymond James & Associates' holdings in Option Care Health were worth $1,686,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of OPCH. Wellington Management Group LLP lifted its holdings in shares of Option Care Health by 15.9% in the third quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company's stock valued at $93,698,000 after purchasing an additional 397,627 shares in the last quarter. Ontario Teachers Pension Plan Board purchased a new stake in shares of Option Care Health in the third quarter valued at $546,000. Van ECK Associates Corp lifted its holdings in shares of Option Care Health by 244.2% in the third quarter. Van ECK Associates Corp now owns 34,291 shares of the company's stock valued at $1,109,000 after purchasing an additional 24,328 shares in the last quarter. Graham Capital Management L.P. purchased a new stake in shares of Option Care Health in the third quarter valued at $2,816,000. Finally, Natixis Advisors L.P. lifted its holdings in shares of Option Care Health by 61.8% in the third quarter. Natixis Advisors L.P. now owns 133,080 shares of the company's stock valued at $4,306,000 after purchasing an additional 50,814 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 35,000 shares of the company's stock in a transaction dated Monday, February 26th. The shares were acquired at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the completion of the purchase, the director now owns 269,528 shares of the company's stock, valued at approximately $8,503,608.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Stock Up 2.1 %

NASDAQ OPCH traded up $0.63 during trading on Thursday, hitting $30.90. 1,573,277 shares of the company traded hands, compared to its average volume of 1,203,002. Option Care Health, Inc. has a 12 month low of $24.23 and a 12 month high of $35.74. The business has a fifty day simple moving average of $32.31 and a 200 day simple moving average of $31.58. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $5.37 billion, a P/E ratio of 21.02, a PEG ratio of 1.78 and a beta of 1.22.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Thursday, February 22nd. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.09 billion. Option Care Health had a return on equity of 18.78% and a net margin of 6.21%. The business's revenue was up 9.5% compared to the same quarter last year. During the same period last year, the company earned $0.26 earnings per share. As a group, sell-side analysts predict that Option Care Health, Inc. will post 1.13 EPS for the current year.

Analyst Upgrades and Downgrades

OPCH has been the subject of several recent research reports. Barrington Research increased their price objective on Option Care Health from $35.00 to $38.00 and gave the stock an "outperform" rating in a report on Friday, February 23rd. Jefferies Financial Group increased their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "buy" rating in a report on Monday, March 4th.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.